Brought to you by 
Series A leads to $19.3mm for Sera Prognostics
07 Dec 2011
Executive Summary
Sera Prognostics Inc. (diagnostics to predict pregnancy complications) has raised $19.3mm through its Series A venture round. New investors InterWest Partners, Domain Associates, and Catalyst Health Ventures led the financing and will each contribute one board member. They were joined by the company’s founder, UpStart Life Sciences Capital, and new backer Osage University Partners.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series A leads to $19.3mm for Sera Prognostics
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice